Primary Site >> Biliary tract Cancer
Gene >> EZH2
| 1. | |||||||||||
| Journal: | Lab Invest. 2008 Aug;88(8):873-82. | ||||||||||
| Title: | The overexpression of polycomb group proteins Bmi1 and EZH2 is associated with the progression and aggressive biological behavior of hepatocellular carcinoma. | ||||||||||
| Author: | Sasaki, Motoko|Ikeda, Hiroko|Itatsu, Keita|Yamaguchi, Junpei|Sawada, Seiko|Minato, Hiroshi|Ohta, Tetsuo|Nakanuma, Yasuni | ||||||||||
| PMID: | 18591938 | ||||||||||
| 2. | |||||||||||
| Journal: | J Pathol. 2008 Jun;215(2):175-83. | ||||||||||
| Title: | Over-expression of polycomb group protein EZH2 relates to decreased expression of p16 INK4a in cholangiocarcinogenesis in hepatolithiasis. | ||||||||||
| Author: | Sasaki, M|Yamaguchi, J|Itatsu, K|Ikeda, H|Nakanuma, Y | ||||||||||
| PMID: | 18393368 | ||||||||||
| 3. | |||||||||||
| Journal: | Lab Invest. 2009 Sep;89(9):1018-31. | ||||||||||
| Title: | Papillary hyperplasia of the gallbladder in pancreaticobiliary maljunction represents a senescence-related lesion induced by lysolecithin. | ||||||||||
| Author: | Yamaguchi, Junpei|Sasaki, Motoko|Harada, Kenichi|Zen, Yoh|Sato, Yasunori|Ikeda, Hiroko|Itatsu, Keita|Yokoyama, Yukihiro|Ando, Hisami|Ohta, Tetsuo|Kubota, Akio|Shimizu, Koichi|Nimura, Yuji|Nagino, Masato|Nakanuma, Yasuni | ||||||||||
| PMID: | 19564843 | ||||||||||
| 4. | |||||||||||
| Journal: | World J Hepatol. 2009 Oct 31;1(1):35-42. | ||||||||||
| Title: | Multistep carcinogenesis of perihilar cholangiocarcinoma arising in the intrahepatic large bile ducts. | ||||||||||
| Author: | Nakanuma, Yasuni|Sasaki, Motoko|Sato, Yasunori|Ren, Xiangshan|Ikeda, Hiroko|Harada, Kenichi | ||||||||||
| PMID: | 21160963 | ||||||||||
| 5. | |||||||||||
| Journal: | Cancer Sci. 2010 Feb;101(2):355-62. | ||||||||||
| Title: | Histone deacetylase inhibitor (SAHA) and repression of EZH2 synergistically inhibit proliferation of gallbladder carcinoma. | ||||||||||
| Author: | Yamaguchi, Junpei|Sasaki, Motoko|Sato, Yasunori|Itatsu, Keita|Harada, Kenichi|Zen, Yoh|Ikeda, Hiroko|Nimura, Yuji|Nagino, Masato|Nakanuma, Yasuni | ||||||||||
| PMID: | 19860841 | ||||||||||
| 6. | |||||||||||
| Journal: | Pathol Res Pract. 2011 Aug 15;207(8):472-8. | ||||||||||
| Title: | Overexpression of EZH2 and loss of expression of PTEN is associated with invasion, metastasis, and poor progression of gallbladder adenocarcinoma. | ||||||||||
| Author: | Liu, Dong-Cai|Yang, Zhu-Lin | ||||||||||
| PMID: | 21719208 | ||||||||||
| 7. | |||||||||||
| Journal: | Histopathology. 2013 Feb;62(3):446-57. | ||||||||||
| Title: | Overexpression of enhancer of zeste homolog 2 and MUC1 may be related to malignant behaviour in intraductal papillary neoplasm of the bile duct. | ||||||||||
| Author: | Sasaki, Motoko|Matsubara, Takashi|Yoneda, Norihide|Nomoto, Kazuhiro|Tsuneyama, Koichi|Sato, Yasunori|Nakanuma, Yasuni | ||||||||||
| PMID: | 23163606 | ||||||||||
| 8. | |||||||||||
| Journal: | Ann Surg Oncol. 2013 Dec;20 Suppl 3:S667-75. | ||||||||||
| Title: | Enhancer of zeste homolog 2 (EZH2) promotes progression of cholangiocarcinoma cells by regulating cell cycle and apoptosis. | ||||||||||
| Author: | Nakagawa, Shigeki|Okabe, Hirohisa|Sakamoto, Yasuo|Hayashi, Hiromitsu|Hashimoto, Daisuke|Yokoyama, Naomi|Sakamoto, Keita|Kuroki, Hideyuki|Mima, Kosuke|Nitta, Hidetoshi|Imai, Katsunori|Chikamoto, Akira|Watanabe, Masayuki|Beppu, Toru|Baba, Hideo | ||||||||||
| PMID: | 23887863 | ||||||||||
| 9. | |||||||||||
| Journal: | Am J Surg Pathol. 2014 Mar;38(3):364-9. | ||||||||||
| Title: | Immunostaining for polycomb group protein EZH2 and senescent marker p16INK4a may be useful to differentiate cholangiolocellular carcinoma from ductular reaction and bile duct adenoma. | ||||||||||
| Author: | Sasaki, Motoko|Matsubara, Takashi|Kakuda, Yuko|Sato, Yasunori|Nakanuma, Yasuni | ||||||||||
| PMID: | 24487593 | ||||||||||
| 10. | |||||||||||
| Journal: | Med Oncol. 2014 Nov;31(11):271. | ||||||||||
| Title: | EZH2 elevates the proliferation of human cholangiocarcinoma cells through the downregulation of RUNX3. | ||||||||||
| Author: | Tang, Bo|Du, Jian|Li, Yang|Tang, Fang|Wang, Zhenran|He, Songqing | ||||||||||
| PMID: | 25280519 | ||||||||||
| 11. | |||||||||||
| Journal: | Oncol Rep. 2014 Feb;31(2):983-8. | ||||||||||
| Title: | Epigenetic therapy with the histone methyltransferase EZH2 inhibitor 3-deazaneplanocin A inhibits the growth of cholangiocarcinoma cells. | ||||||||||
| Author: | Nakagawa, Shigeki|Sakamoto, Yasuo|Okabe, Hirohisa|Hayashi, Hiromitsu|Hashimoto, Daisuke|Yokoyama, Naomi|Tokunaga, Ryuma|Sakamoto, Keita|Kuroki, Hideyuki|Mima, Kosuke|Beppu, Toru|Baba, Hideo | ||||||||||
| PMID: | 24337160 | ||||||||||
| 12. | |||||||||||
| Journal: | Histol Histopathol. 2015 Mar;30(3):267-75. | ||||||||||
| Title: | Cellular senescence in biliary pathology. Special emphasis on expression of a polycomb group protein EZH2 and a senescent marker p16INK4a in bile ductular tumors and lesions. | ||||||||||
| Author: | Sasaki, Motoko|Nakanuma, Yasuni | ||||||||||
| PMID: | 25289642 | ||||||||||
| 13. | |||||||||||
| Journal: | Cancer Lett. 2016 Sep 28;380(1):122-33. | ||||||||||
| Title: | Long non-coding RNA MINCR promotes gallbladder cancer progression through stimulating EZH2 expression. | ||||||||||
| Author: | Wang, Shou-Hua|Yang, Yong|Wu, Xiao-Cai|Zhang, Ming-Di|Weng, Ming-Zhe|Zhou, Di|Wang, Jian-Dong|Quan, Zhi-Wei | ||||||||||
| PMID: | 27345740 | ||||||||||
| 14. | |||||||||||
| Journal: | Oncotarget. 2017 Jul 18;8(29):47957-47968. | ||||||||||
| Title: | Long non-coding RNA UCA1 promotes gallbladder cancer progression by epigenetically repressing p21 and E-cadherin expression. | ||||||||||
| Author: | Cai, Qiang|Jin, Longyang|Wang, Shouhua|Zhou, Di|Wang, Jiandong|Tang, Zhaohui|Quan, Zhiwei | ||||||||||
| PMID: | 28624787 | ||||||||||
| 15. | |||||||||||
| Journal: | Am J Pathol. 2017 Oct;187(10):2288-2299. | ||||||||||
| Title: | Epigenetic Silencing of miRNA-34a in Human Cholangiocarcinoma via EZH2 and DNA Methylation: Impact on Regulation of Notch Pathway. | ||||||||||
| Author: | Kwon, Hyunjoo|Song, Kyoungsub|Han, Chang|Zhang, Jinqiang|Lu, Lu|Chen, Weina|Wu, Tong | ||||||||||
| PMID: | 28923203 | ||||||||||
| 16. | |||||||||||
| Journal: | Cell Death Dis. 2018 Feb 14;9(2):249. | ||||||||||
| Title: | Let-7c inhibits cholangiocarcinoma growth but promotes tumor cell invasion and growth at extrahepatic sites. | ||||||||||
| Author: | Xie, Yu|Zhang, Hang|Guo, Xing-Jun|Feng, Ye-Chen|He, Rui-Zhi|Li, Xu|Yu, Shuo|Zhao, Yan|Shen, Ming|Zhu, Feng|Wang, Xin|Wang, Min|Balakrishnan, Asha|Ott, Michael|Peng, Feng|Qin, Ren-Yi | ||||||||||
| PMID: | 29445149 | ||||||||||
| 17. | |||||||||||
| Journal: | HPB (Oxford). 2018 May 11. pii: S1365-182X(18)30795-0. | ||||||||||
| Title: | Enhancer of zeste homolog 2 (EZH2) regulates tumor angiogenesis and predicts recurrence and prognosis of intrahepatic cholangiocarcinoma. | ||||||||||
| Author: | Nakagawa, Shigeki|Okabe, Hirohisa|Ouchi, Mayuko|Tokunaga, Ryuma|Umezaki, Naoki|Higashi, Takaaki|Kaida, Takatoshi|Arima, Kota|Kitano, Yuki|Kuroki, Hideyuki|Mima, Kosuke|Nitta, Hidetoshi|Imai, Katsunori|Hashimoto, Daisuke|Yamashita, Yo-Ichi|Chikamoto, Akira | ||||||||||
| PMID: | 29759640 | ||||||||||
| 18. | |||||||||||
| Journal: | Cell Death Dis. 2018 Jul 3;9(7):746. | ||||||||||
| Title: | Epigenetic silencing of tumor suppressor gene CDKN1A by oncogenic long non-coding RNA SNHG1 in cholangiocarcinoma. | ||||||||||
| Author: | Yu, Yang|Zhang, Mingjiong|Wang, Ni|Li, Quanpeng|Yang, Jian|Yan, Shuai|He, Xuezhi|Ji, Guozhong|Miao, Lin | ||||||||||
| PMID: | 29970899 | ||||||||||
| 19. | |||||||||||
| Journal: | Cell Death Dis. 2018 Oct 3;9(10):1017. | ||||||||||
| Title: | Long noncoding RNA MEG3 regulates LATS2 by promoting the ubiquitination of EZH2 and inhibits proliferation and invasion in gallbladder cancer. | ||||||||||
| Author: | Jin, Longyang|Cai, Qiang|Wang, Shouhua|Wang, Shuqing|Mondal, Tanmoy|Wang, Jiandong|Quan, Zhiwei | ||||||||||
| PMID: | 30282996 | ||||||||||